Gene · 134864
Papers1,472
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,472
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| New Pharmacological Treatment Approaches for Schizophrenia: Navigating the Post-iclepertin Landscape. | CNS Drugs | 2026 | 41609993 | PubTator, text mining | PubMed |
| Clinical Effects of Recently Developed Antipsychotic Drugs in Schizophrenia. | Cent Nerv Syst Agents Med Chem | 2026 | 41588897 | PubTator, text mining | PubMed |
| Betaine mediated m6A methylation: a strategy for improving tolerance in pepper seedlings to low temperature combined with low light stress. | Int J Biol Macromol | 2026 | 41581801 | PubTator, text mining | PubMed |
| Management of Parkinson's disease psychosis-a European perspective. | Lancet Reg Health Eur | 2026 | 41552366 | PubTator, text mining | PubMed |
| The TAAR1 antagonist EPPTB ameliorates colitis via serotonin inhibition. | Biochem Biophys Rep | 2026 | 41550498 | PubTator, text mining | PubMed |
| Emerging Innovations in Third- and Fourth-Generation Antipsychotics: Mechanistic Advances and Clinical Implications. | Psychopharmacol Bull | 2026 | 41532001 | PubTator, text mining | PubMed |
| Potential of Small Molecule TAAR-1 Agonists for the Therapy of Neurodegenerative Psychosis: A Medicinal Chemistry Perspective. | Mini Rev Med Chem | 2026 | 41487003 | PubTator, text mining | PubMed |
| TAAR1 Regulates Presynaptic Dopamine Function: Evidence From Preclinical Studies and a Phase 1b Trial in Patients With Schizophrenia. | Biol Psychiatry | 2026 | 41130556 | PubTator, text mining | PubMed |
| A double-blind study on ulotaront's impact on weight-related parameters in schizophrenia patients with metabolic syndrome and prediabetes: Part II. | Diabetes Obes Metab | 2026 | 41126397 | PubTator, text mining | PubMed |
| An open-label study on ulotaront's effects on insulin-glucose regulation in schizophrenia patients with metabolic syndrome and prediabetes: Part I. | Diabetes Obes Metab | 2026 | 41126393 | PubTator, text mining | PubMed |
| The Role of Trace Amine-Associated Receptor 1 (TAAR1) in the Pathophysiology and Treatment of Depression. | Curr Neuropharmacol | 2026 | 40600536 | PubTator, text mining | PubMed |
| Nuclear m6A modification regulates satellite transcription and chromosome segregation. | Nat Chem Biol | 2026 | 40404899 | PubTator, text mining | PubMed |
| Predicting the Risk of Adverse Neonatal Outcomes in Women With Insulin-Treated Diabetes: Is It Time for a Pregnancy-Specific Glycemic Risk Index? | J Diabetes Sci Technol | 2026 | 39417492 | PubTator, text mining | PubMed |
| Trace Amine-associated Receptor 1: Role in the Implementation of Neuroprotective Signaling Pathways. | Int J Mol Cell Med | 2025 | 42016024 | PubTator, text mining | PubMed |
| New Insights into Complex PTSD Treatment: Focus on TAAR1 Agonists. | Biomedicines | 2025 | 41462983 | PubTator, text mining | PubMed |
| Aging and Thymosin Alpha-1. | Int J Mol Sci | 2025 | 41373628 | PubTator, text mining | PubMed |
| Methamphetamine and neuroHIV suppress astrocytic potassium channel function in the medial prefrontal cortex via different mechanisms. | Front Pharmacol | 2025 | 41368584 | PubTator, text mining | PubMed |
| Receptor interaction profiles of 4-alkoxy-2,6-dimethoxyphenethylamines (Ψ derivatives) and related amphetamines. | Front Pharmacol | 2025 | 41357866 | PubTator, text mining | PubMed |
| Thymosin α1 Combined with PD-1/PD-L1 Inhibitor Plus Chemotherapy in Platinum-Resistant Recurrent Ovarian Cancer : A Retrospective Analysis. | Cancer Manag Res | 2025 | 41356424 | PubTator, text mining | PubMed |
| The Fine Structure of Genome Statistics-The Frequency and Size. | Life (Basel) | 2025 | 41302073 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/134864/papers?page=3